Edgar Filing: HEALTHSOUTH CORP

10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

______________________________

FORM 10-Q



ý	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2016



o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-10315

______________________________

HealthSouth Corporation

(Exact name of Registrant as specified in its Charter)



Delaware	63-0860407
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

3660 Grandview Parkway, Suite 200 Birmingham, Alabama	35243
(Address of Principal Executive Offices)	(Zip Code)

(205) 967-7116
(Registrant’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ý Accelerated filer o Non-Accelerated filer o Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Exchange Act Rule 12b-2). Yes o No ý

The registrant had 90,014,022 shares of common stock outstanding, net of treasury shares, as of April 20, 2016.

TABLE OF CONTENTS



		Page
PART I	Financial Information

Item 1.	Financial Statements (Unaudited)	1
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	31
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	50
Item 4.	Controls and Procedures	50

PART II	Other Information

Item 1.	Legal Proceedings	51
Item 1A.	Risk Factors	51
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	51
Item 6.	Exhibits	52

NOTE TO READERS

As used in this report, the terms “HealthSouth,” “we,” “us,” “our,” and the “Company” refer to HealthSouth Corporation and its consolidated subsidiaries, unless otherwise stated or indicated by context. This drafting style is suggested by the Securities and Exchange Commission and is not meant to imply that HealthSouth Corporation, the publicly traded parent company, owns or operates any specific asset, business, or property. The hospitals, operations, and businesses described in this filing are primarily owned and operated by subsidiaries of the parent company. In addition, we use the term “HealthSouth Corporation” to refer to HealthSouth Corporation alone wherever a distinction between HealthSouth Corporation and its subsidiaries is required or aids in the understanding of this filing.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This quarterly report contains historical information, as well as forward-looking statements that involve known and unknown risks and relate to, among other things, future events, changes to Medicare reimbursement and other healthcare laws and regulations from time to time, our business strategy, our dividend and stock repurchase strategies, our financial plans, our growth plans, our future financial performance, our projected business results, or our projected capital expenditures. In some cases, the reader can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “targets,” “potential,” or “continue” or the negative of these terms or other comparable terminology. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties, many of which are beyond our control. Any forward-looking statement is based on information current as of the date of this report and speaks only as of the date on which such statement is made. Actual events or results may differ materially from the results anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by us include, but are not limited to, the following:


•	each of the factors discussed in Item 1A, Risk Factors, of our Annual Report on Form 10-K for the year ended December 31, 2015, as well as uncertainties and factors discussed in Part II, Item 1A, Risk Factors, and elsewhere in this Form 10-Q, in our other filings from time to time with the SEC, or in materials incorporated therein by reference;

•

changes in the rules and regulations of the healthcare industry at either or both of the federal and state levels, including those contemplated now and in the future as part of national healthcare reform and deficit reduction such as the reinstatement of the “75% Rule” or the introduction of site neutral payments with skilled nursing facilities for certain conditions, and related increases in the costs of complying with such changes;


•	reductions or delays in, or suspension of, reimbursement for our services by governmental or private payors, including our ability to obtain and retain favorable arrangements with third-party payors;


•	delays in the administrative appeals process associated with denied Medicare reimbursement claims, including from various Medicare audit programs, and our exposure to the related delay or reduction in the receipt of the reimbursement amounts for services previously provided;


•	the ongoing evolution of the healthcare delivery system, including alternative payment models and value-based purchasing initiatives;


•	our ability to comply with extensive and changing healthcare regulations as well as the increased costs of regulatory compliance and compliance monitoring in the healthcare industry, including the costs of investigating and defending asserted claims, whether meritorious or not;


•	our ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on our labor expenses from potential union activity and staffing recruitment and retention;


•	competitive pressures in the healthcare industry and our response to those pressures;


•	changes in our payor mix or the acuity of our patients;


•	our ability to successfully complete and integrate de novo developments, acquisitions, investments, and joint ventures consistent with our growth strategy, including realization of anticipated revenues, cost savings, and productivity improvements arising from the related operations;


•	any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings, including the ongoing investigations initiated by the U.S. Department of Health and Human Services, Office of the Inspector General;


•	increased costs of defending and insuring against alleged professional liability and other claims and the ability to predict the costs related to such claims;


•	potential incidents affecting the proper operation, availability, or security of our information systems;


•	new or changing quality reporting requirements impacting operational costs or our Medicare reimbursement;


•	the price of our common stock as it affects our willingness and ability to repurchase shares and the financial and accounting effects of any repurchases;


•	our ability and willingness to continue to declare and pay dividends on our common stock;

•

our ability to successfully integrate Encompass Home Health and Hospice, the inpatient rehabilitation hospitals acquired from Reliant Hospital Partners, LLC, and the home health agency operations of CareSouth Health System, Inc., including the realization of anticipated benefits from those acquisitions and avoidance of unanticipated difficulties, costs or liabilities that could arise from the acquisitions or integrations;


•	our ability to maintain proper local, state and federal licensing where we and our subsidiaries do business;


•	our ability to attract and retain key management personnel, including as a part of executive management succession planning; and


•	general conditions in the economy and capital markets, including any instability or uncertainty related to governmental impasse over approval of the United States federal budget, an increase to the debt ceiling, or an international sovereign debt crisis.

The cautionary statements referred to in this section also should be considered in connection with any subsequent written or oral forward-looking statements that may be issued by us or persons acting on our behalf. We undertake no duty to update these forward-looking statements, even though our situation may change in the future. Furthermore, we cannot guarantee future results, events, levels of activity, performance, or achievements.

PART I. FINANCIAL INFORMATION


Item 1.	Financial Statements (Unaudited)

HealthSouth Corporation and Subsidiaries

Condensed Consolidated Statements of Operations

(Unaudited)



	Three Months Ended March 31,
	2016			2015
	(In Millions)
Net operating revenues	$	909.8		$	740.6
Less: Provision for doubtful accounts	(16.5		)	(11.6		)
Net operating revenues less provision for doubtful accounts	893.3			729.0
Operating expenses:
Salaries and benefits	486.1			385.1
Other operating expenses	119.2			103.2
Occupancy costs	18.0			12.1
Supplies	35.0			31.4
General and administrative expenses	31.9			34.6
Depreciation and amortization	42.4			31.9
Government, class action, and related settlements	—			8.0
Professional fees—accounting, tax, and legal	0.2			2.2
Total operating expenses	732.8			608.5
Loss on early extinguishment of debt	2.4			1.2
Interest expense and amortization of debt discounts and fees	44.6			31.8
Other income	(0.6		)	(0.5		)
Equity in net income of nonconsolidated affiliates	(2.4		)	(1.6		)
Income from continuing operations before income tax expense	116.5			89.6
Provision for income tax expense	39.7			30.3
Income from continuing operations	76.8			59.3
Loss from discontinued operations, net of tax	(0.1		)	(0.3		)
Net income	76.7			59.0
Less: Net income attributable to noncontrolling interests	(18.7		)	(16.5		)
Net income attributable to HealthSouth	58.0			42.5
Less: Convertible perpetual preferred stock dividends	—			(1.6		)
Net income attributable to HealthSouth common shareholders	$	58.0		$	40.9

(Continued)

HealthSouth Corporation and Subsidiaries

Condensed Consolidated Statements of Operations (Continued)

(Unaudited)



	Three Months Ended March 31,
	2016			2015
	(In Millions, Except Per Share Data)
Weighted average common shares outstanding:
Basic	89.5			87.1
Diluted	99.4			101.1

Earnings per common share:
Basic earnings per share attributable to HealthSouth common shareholders:
Continuing operations	$	0.65		$	0.47
Discontinued operations	—			—
Net income	$	0.65		$	0.47
Diluted earnings per share attributable to HealthSouth common shareholders:
Continuing operations	$	0.61		$	0.44
Discontinued operations	—			—
Net income	$	0.61		$	0.44

Cash dividends per common share	$	0.23		$	0.21

Amounts attributable to HealthSouth common shareholders:
Income from continuing operations	$	58.1		$	42.8
Loss from discontinued operations, net of tax	(0.1		)	(0.3		)
Net income attributable to HealthSouth	$	58.0		$	42.5

The accompanying notes to condensed consolidated financial statements are an integral part of these condensed statements.

HealthSouth Corporation and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income

(Unaudited)



	Three Months Ended March 31,
	2016			2015
	(In Millions)
COMPREHENSIVE INCOME
Net income	$	76.7		$	59.0
Other comprehensive income, net of tax:
Net change in unrealized gain on available-for-sale securities:
Unrealized net holding gain arising during the period	0.2			0.1
Other comprehensive income before income taxes	0.2			0.1
Provision for income tax expense related to other comprehensive income items	(0.1		)	—
Other comprehensive income, net of tax	0.1			0.1
Comprehensive income	76.8			59.1
Comprehensive income attributable to noncontrolling interests	(18.7		)	(16.5		)
Comprehensive income attributable to HealthSouth	$	58.1		$	42.6

The accompanying notes to condensed consolidated financial statements are an integral part of these condensed statements.

HealthSouth Corporation and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited)



	March 31, 2016		December 31, 2015
	(In Millions)
Assets
Current assets:
Cash and cash equivalents	$	73.2	$	61.6
Accounts receivable, net of allowance for doubtful accounts of $44.7 in 2016; $39.3 in 2015	431.9		410.5
Other current assets	127.0		126.6
Total current assets	632.1		598.7
Property and equipment, net	1,317.7		1,310.1
Goodwill	1,891.9		1,890.1
Intangible assets, net	415.8		419.4
Deferred income tax assets	145.0		190.8
Other long-term assets	205.8		197.0
Total assets⁽¹⁾	$	4,608.3	$	4,606.1
Liabilities and Shareholders’ Equity
Current liabilities:
Current portion of long-term debt	$	36.6	$	36.8
Accounts payable	62.7		61.6
Accrued expenses and other current liabilities	364.5		328.0
Total current liabilities	463.8		426.4
Long-term debt, net of current portion	3,079.6		3,134.7
Other long-term liabilities	144.8		144.6
	3,688.2		3,705.7
Commitments and contingencies
Redeemable noncontrolling interests	96.2		121.1
Shareholders’ equity:
HealthSouth shareholders’ equity	649.5		611.4
Noncontrolling interests	174.4		167.9
Total shareholders’ equity	823.9		779.3
Total liabilities⁽¹⁾and shareholders’ equity	$	4,608.3	$	4,606.1


⁽¹⁾	Our consolidated assets as of March 31, 2016 include total assets of variable interest entities of $247.3 million, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of March 31, 2016 include total liabilities of the variable interest entities of $54.0 million. See Note 3, Variable Interest Entities.

The accompanying notes to condensed consolidated financial statements are an integral part of these condensed statements.

HealthSouth Corporation and Subsidiaries

Condensed Consolidated Statements of Shareholders’ Equity

(Unaudited)



	Three Months Ended March 31, 2016
	(In Millions)
	HealthSouth Common Shareholders
	Number of Common Shares Outstanding		Common Stock		Capital in Excess of Par Value			Accumulated Deficit			Accumulated Other Comprehensive Loss			Treasury Stock			Noncontrolling Interests			Total
Balance at beginning of period	90.1		$	1.1	$	2,834.9		$	(1,696.0	)	$	(1.2	)	$	(527.4	)	$	167.9		$	779.3
Net income	—		—		—			58.0			—			—			14.8			72.8
Receipt of treasury stock	(0.4	)	—		—			—			—			(9.9		)	—			(9.9		)
Dividends declared on common stock	—		—		(20.8		)	—			—			—			—			(20.8		)
Stock-based compensation	—		—		5.9			—			—			—			—			5.9
Stock options exercised	0.2		—		5.0			—			—			(4.6		)	—			0.4
Distributions declared	—		—		—			—			—			—			(17.1		)	(17.1		)
Capital contributions from consolidated affiliates	—		—		—			—			—			—			7.4			7.4
Fair value adjustments to redeemable noncontrolling interests, net of tax	—		—		16.3			—			—			—			—			16.3
Repurchases of common stock in open market	(0.4	)	—		—			—			—			(12.9		)	—			(12.9		)
Other	0.5		—		1.2			—			0.1			(0.2		)	1.4			2.5
Balance at end of period	90.0		$	1.1	$	2,842.5		$	(1,638.0	)	$	(1.1	)	$	(555.0	)	$	174.4		$	823.9



	Three Months Ended March 31, 2015
	(In Millions)
	HealthSouth Common Shareholders
	Number of Common Shares Outstanding		Common Stock		Capital in Excess of Par Value			Accumulated Deficit			Accumulated Other Comprehensive Loss			Treasury Stock			Noncontrolling Interests			Total
Balance at beginning of period	87.8		$	1.0	$	2,810.5		$	(1,879.1	)	$	(0.5	)	$	(458.7	)	$	146.3		$	619.5
Net income	—		—		—			42.5			—			—			13.6			56.1
Receipt of treasury stock	(0.5	)	—		—			—			—			(14.9		)	—			(14.9		)
Dividends declared on common stock	—		—		(18.7		)	—			—			—			—			(18.7		)
Dividends declared on convertible perpetual preferred stock	—		—		(1.6		)	—			—			—			—			(1.6		)
Stock-based compensation	—		—		9.1			—			—			—			—			9.1
Stock options exercised	0.2		—		5.5			—			—			(3.6		)	—			1.9
Distributions declared	—		—		—			—			—			—			(12.4		)	(12.4		)
Other	0.7		—		0.8			—			0.1			(0.1		)	0.6			1.4
Balance at end of period	88.2		$	1.0	$	2,805.6		$	(1,836.6	)	$	(0.4	)	$	(477.3	)	$	148.1		$	640.4

The accompanying notes to condensed consolidated financial statements are an integral part of these condensed statements.

HealthSouth Corporation and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)



	Three Months Ended March 31,
	2016			2015
	(In Millions)
Cash flows from operating activities:
Net income	$	76.7		$	59.0
Loss from discontinued operations, net of tax	0.1			0.3
Adjustments to reconcile net income to net cash provided by operating activities—
Provision for doubtful accounts	16.5			11.6
Depreciation and amortization	42.4			31.9
Equity in net income of nonconsolidated affiliates	(2.4		)	(1.6		)
Distributions from nonconsolidated affiliates	1.7			1.9
Stock-based compensation	4.5			9.4
Deferred tax expense	34.7			26.8
Other	5.9			10.8
Change in assets and liabilities—
Accounts receivable	(45.7		)	(37.3		)
Other assets	1.8			(2.9		)
Accounts payable	0.6			2.1
Accrued payroll	20.9			(23.3		)
Other liabilities	4.1			5.4
Premium received on bond issuance	—			8.0
Premium paid on redemption of bonds	(1.9		)	—
Net cash used in operating activities of discontinued operations	(0.2		)	(0.1		)
Total adjustments	82.9			42.7
Net cash provided by operating activities	159.7			102.0

(Continued)

HealthSouth Corporation and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Continued)

(Unaudited)



	Three Months Ended March 31,
	2016			2015
	(In Millions)
Cash flows from investing activities:
Purchases of property and equipment	(31.4		)	(17.7		)
Capitalized software costs	(7.7		)	(8.9		)
Acquisitions of businesses, net of cash acquired	—			(7.3		)
Net change in restricted cash	(3.2		)	(15.0		)
Other	2.8			3.2
Net cash used in investing activities	(39.5		)	(45.7		)
Cash flows from financing activities:
Proceeds from bond issuance	—			700.0
Principal payments on debt, including pre-payments	(56.3		)	(252.9		)
Borrowings on revolving credit facility	60.0			35.0
Payments on revolving credit facility	(60.0		)	(350.0		)
Debt amendment and issuance costs	—			(13.7		)
Repurchases of common stock, including fees and expenses	(12.9		)	—
Dividends paid on common stock	(21.3		)	(18.6		)
Dividends paid on convertible perpetual preferred stock	—			(1.6		)
Distributions paid to noncontrolling interests of consolidated affiliates	(15.6		)	(13.2		)
Other	(2.5		)	0.3
Net cash (used in) provided by financing activities	(108.6		)	85.3
Increase in cash and cash equivalents	11.6			141.6
Cash and cash equivalents at beginning of period	61.6			66.7
Cash and cash equivalents at end of period	$	73.2		$	208.3

The accompanying notes to condensed consolidated financial statements are an integral part of these condensed statements.

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements


1.	Basis of Presentation

HealthSouth Corporation, incorporated in Delaware in 1984, including its subsidiaries, is one of the nation’s largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services in 34 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies.

The accompanying unaudited condensed consolidated financial statements of HealthSouth Corporation and Subsidiaries should be read in conjunction with the consolidated financial statements and accompanying notes filed with the United States Securities and Exchange Commission in HealthSouth’s Annual Report on Form 10-K filed on February 24, 2016 (the “2015 Form 10-K”). The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the SEC applicable to interim financial information. Certain information and note disclosures included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been omitted in these interim statements, as allowed by such SEC rules and regulations. The condensed consolidated balance sheet as of December 31, 2015 has been derived from audited financial statements, but it does not include all disclosures required by GAAP. However, we believe the disclosures are adequate to make the information presented not misleading.

The unaudited results of operations for the interim periods shown in these financial statements are not necessarily indicative of operating results for the entire year. In our opinion, the accompanying condensed consolidated financial statements recognize all adjustments of a normal recurring nature considered necessary to fairly state the financial position, results of operations, and cash flows for each interim period presented.

See also Note 12, Segment Reporting.

Variable Interest Entities—

Effective January 1, 2016, in connection with our adoption of ASU 2015-02, we updated our evaluation of all jointly held legal entities to determine whether they are now variable interest entities (“VIEs”) under the new guidance. Any entity considered a VIE is evaluated to determine which party is the primary beneficiary and thus should consolidate the VIE. This analysis is complex, involves uncertainties, and requires significant judgment on various matters. In order to determine if we are the primary beneficiary of a VIE, we must determine what activities most significantly impact the economic performance of the entity, whether we have the power to direct those activities, and if our obligation to absorb losses or receive benefits from the VIE could potentially be significant to the VIE.

Net Operating Revenues—

We derived consolidated Net operating revenues from the following payor sources:



	Three Months Ended March 31,
	2016		2015
Medicare	75.4	%	74.9	%
Medicare Advantage	7.8	%	8.2	%
Managed care	9.5	%	10.0	%
Medicaid	3.4	%	2.6	%
Other third-party payors	1.4	%	1.5	%
Workers’ compensation	0.9	%	0.9	%
Patients	0.5	%	0.7	%
Other income	1.1	%	1.2	%
Total	100.0	%	100.0	%

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

Inpatient Rehabilitation Revenues

Our inpatient rehabilitation segment derived its Net operating revenues from the following payor sources:



	Three Months Ended March 31,
	2016		2015
Medicare	73.8	%	73.5	%
Medicare Advantage	7.6	%	8.3	%
Managed care	11.0	%	11.2	%
Medicaid	3.0	%	2.0	%
Other third-party payors	1.6	%	1.7	%
Workers’ compensation	1.1	%	1.1	%
Patients	0.6	%	0.8	%
Other income	1.3	%	1.4	%
Total	100.0	%	100.0	%

Home Health and Hospice Revenues

Our home health and hospice segment derived its Net operating revenues from the following payor sources:



	Three Months Ended March 31,
	2016		2015
Medicare	83.5	%	83.8	%
Medicare Advantage	8.7	%	7.3	%
Managed care	2.7	%	3.1	%
Medicaid	4.9	%	5.6	%
Other third-party payors	—	%	0.1	%
Patients	0.1	%	0.1	%
Other income	0.1	%	—	%
Total	100.0	%	100.0	%

See Note 1, Summary of Significant Accounting Policies, to the consolidated financial statements accompanying the 2015 Form 10-K for our policies related to Net operating revenues, Accounts receivable, and our Allowance for doubtful accounts.

Recent Accounting Pronouncements—

In February 2015, the FASB issued ASU 2015-02, “Consolidations (Topic 810) - Amendments to the Consolidation Analysis,” which provides guidance on evaluating whether a reporting entity should consolidate certain legal entities. Specifically, the amendments modify the evaluation of whether limited partnerships and similar legal entities are VIEs. Under this analysis, limited partnerships and other similar entities will be considered a VIE unless the limited partners hold substantive kick-out rights or participating rights. Further, the amendments eliminate the presumption that a general partner should consolidate a limited partnership under the voting interest model, as well as affect the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships. This standard was effective for annual periods beginning after December 15, 2015 and interim periods within those annual periods. We elected to adopt this guidance using the modified retrospective approach. Our adoption of this guidance resulted in certain limited partnership-like entities that were previously consolidated as voting interest entities to now be consolidated as VIEs, for

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

which additional disclosures are required. Our adoption of ASU 2015-02 did not have a material impact on our financial position, results of operations, or cash flows. See Note 3, Variable Interest Entities.

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842),” in order to increase transparency and comparability by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements. Under the new standard, lessees will recognize a right-of-use asset and a corresponding lease liability for all leases other than leases that meet the definition of a short-term lease. The liability will be equal to the present value of lease payments. The asset will be based on the liability, subject to adjustment, such as for initial direct costs. For income statement purposes, the FASB retained a dual model, requiring leases to be classified as either operating or finance. Operating leases will result in straight-line expense while finance leases will result in an expense pattern similar to current capital leases. Classification will be based on criteria that are similar to those applied in current lease accounting. This standard will be effective for HealthSouth for the annual reporting period beginning after December 15, 2018. Early adoption is permitted. We continue to review the requirements of this standard and any potential impact it may have on our financial position, results of operations, or cash flows.

In March 2016, the FASB issued ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting (Topic 718),” to simplify various aspects of share-based payment accounting and presentation. The new standard requires entities to record all of the tax effects related to share-based payments at settlement (or expiration) through the income statement. This will require us to reclassify tax benefits in excess of compensation cost (“windfalls”) and tax deficiencies (“shortfalls”) to the extent of previous windfalls from Capital in excess of par value to Provision for income tax expense. This change is required to be applied prospectively to all excess tax benefits and tax deficiencies resulting from settlements after the date of adoption of the ASU. The standard eliminates the requirement to delay recognition of a windfall tax benefit until it reduces current taxes payable. This change is required to be applied on a modified retrospective basis, with a cumulative-effect adjustment to opening retained earnings. In addition, all income tax-related cash flows resulting from share-based payments are required to be reported as operating activities on the statement of cash flows as opposed to the current presentation as an inflow from financing activities and an outflow from operating activities. Either prospective or retrospective transition of this provision is permitted. Finally, the standard clarifies that all cash payments made to taxing authorities on the employees’ behalf for withheld shares should be presented as financing activities on the statement of cash flows. This change will be applied retrospectively. For public companies, this guidance is effective for annual reporting periods beginning after December 15, 2016 and interim periods within that reporting period. Early adoption is permitted, with any adjustments reflected as of the beginning of the fiscal year of adoption. We continue to review the requirements of this standard and any potential impact it may have on our financial position, results of operations, or cash flows.


2.	Business Combinations

In February 2016, we acquired 50% of the inpatient rehabilitation hospital at CHI St. Vincent Hot Springs (“Hot Springs”), a 20-bed inpatient rehabilitation hospital in Hot Springs, Arkansas, through a joint venture with St. Vincent Community Health Services, Inc. The acquisition, which was funded through a contribution to the consolidated joint venture, was not material to our financial position, results of operations, or cash flows. The Hot Springs transaction was made to enhance our position and ability to provide inpatient rehabilitative services to patients in Hot Springs and its surrounding areas. As a result of this transaction, Goodwill increased by $1.8 million, none of which is deductible for federal income tax purposes. The goodwill reflects our expectations of our ability to gain access to and penetrate the acquired hospital’s historical patient base and the benefits of being able to leverage operational efficiencies with favorable growth opportunities based on positive demographic trends in this market.

We accounted for this transaction under the acquisition method of accounting and reported the results of operations of the acquired hospital from its respective date of acquisition. Assets acquired and liabilities assumed, if any, were recorded at their estimated fair values as of the respective acquisition date. The fair value of the identifiable intangible asset was based on valuations using the income approach. The income approach is based on management’s estimates of future operating results and cash flows discounted using a weighted-average cost of capital that reflects market participant assumptions. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill.

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

The fair value of the assets acquired at the acquisition date were as follows (in millions):



Property and equipment	$	5.1
Identifiable intangible asset:
Trade name (useful life of 20 years)	0.2
Goodwill	1.8
Total assets acquired	$	7.1

Information regarding the net cash paid was as follows (in millions):



	Three Months Ended March 31, 2016
Fair value of assets acquired	$	5.3
Goodwill	1.8
Fair value of noncontrolling interest owned by joint venture partner	(7.1		)
Net cash paid for acquisition	$	—

Pro Forma Results of Operations

The following table summarizes the results of operations of the above mentioned transaction from its respective date of acquisition included in our consolidated results of operations and the unaudited pro forma results of operations of the combined entity had the date of the acquisition been January 1, 2015 (in millions):



	Net Operating Revenues		Net Income Attributable to HealthSouth
Acquired entities only: Actual from acquisition date to March 31, 2016	$	0.3	$	(0.7	)
Combined entity: Supplemental pro forma from 01/01/2016-03/31/2016	910.1		58.0
Combined entity: Supplemental pro forma from 01/01/2015-03/31/2015	741.6		42.6

See Note 2, Business Combinations, to the consolidated financial statements accompanying the 2015 Form 10-K for information regarding acquisitions completed in 2015.


3.	Variable Interest Entities

As of March 31, 2016, we consolidated ten limited partnership-like entities that are VIEs and of which we are the primary beneficiary. All ten of these entities were also consolidated as of December 31, 2015. Our ownership percentages in these entities range from 6.8% to 99.5%. Through partnership and management agreements with or governing each of these entities, we manage all of these entities and handle all day-to-day operating decisions. Accordingly, we have the decision making power over the activities that most significantly impact the economic performance of our VIEs and an obligation to absorb losses or receive benefits from the VIE that could potentially be significant to the VIE. These decisions and significant activities include, but are not limited to, marketing efforts, oversight of patient admissions, medical training, nurse and therapist scheduling, provision of healthcare services, billing, collections and creation and maintenance of medical records. The terms of the agreements governing each of our VIEs prohibit us from using the assets of each VIE to satisfy the obligations of other entities.

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

The carrying amounts and classifications of the consolidated VIEs’ assets and liabilities, which are included in our consolidated balance sheet, are as follows (in millions):



	March 31, 2016
Assets
Current assets:
Cash and cash equivalents	$	1.6
Accounts receivable, net of allowance for doubtful accounts	28.9
Other current assets	6.4
Total current assets	36.9
Property and equipment, net	126.8
Goodwill	73.5
Intangible assets, net	9.2
Other long-term assets	0.9
Total assets	$	247.3
Liabilities
Current liabilities:
Current portion of long-term debt	$	1.4
Accounts payable	7.5
Accrued expenses and other current liabilities	14.2
Total current liabilities	23.1
Long-term debt, net of current portion	30.9
Total liabilities	$	54.0


4.	Investments in and Advances to Nonconsolidated Affiliates

As of March 31, 2016 and December 31, 2015, we had $12.5 million and $11.7 million, respectively, of investments in and advances to nonconsolidated affiliates included in Other long-term assets in our condensed consolidated balance sheets. Investments in and advances to nonconsolidated affiliates represent our investments in seven partially owned subsidiaries, of which six are general or limited partnerships, limited liability companies, or joint ventures in which HealthSouth or one of its subsidiaries is a general or limited partner, managing member, member, or venturer, as applicable. We do not control these affiliates but have the ability to exercise significant influence over the operating and financial policies of certain of these affiliates. Our ownership percentages in these affiliates range from approximately 1% to 60%. We account for these investments using the cost and equity methods of accounting.

The following summarizes the combined results of operations of our equity method affiliates (on a 100% basis, in millions):



	Three Months Ended March 31,
	2016			2015
Net operating revenues	$	11.2		$	8.2
Operating expenses	(3.2		)	(3.9		)
Income from continuing operations, net of tax	5.0			3.9
Net income	5.0			3.9

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements


5.	Long-term Debt

Our long-term debt outstanding consists of the following (in millions):



	March 31, 2016			December 31, 2015
Credit Agreement—
Advances under revolving credit facility	$	130.0		$	130.0
Term loan facilities	437.8			443.3
Bonds payable—
7.75% Senior Notes due 2022	124.8			174.3
5.125% Senior Notes due 2023	294.8			294.6
5.75% Senior Notes due 2024	1,192.7			1,192.6
5.75% Senior Notes due 2025	343.5			343.4
2.00% Convertible Senior Subordinated Notes due 2043	268.3			265.9
Other notes payable	38.4			39.2
Capital lease obligations	285.9			288.2
	3,116.2			3,171.5
Less: Current portion	(36.6		)	(36.8		)
Long-term debt, net of current portion	$	3,079.6		$	3,134.7

The following chart shows scheduled principal payments due on long-term debt for the next five years and thereafter (in millions):



	Face Amount		Net Amount
April 1 through December 31, 2016	$	27.8	$	27.8
2017	36.5		36.5
2018	36.6		36.6
2019	39.6		39.6
2020	813.7		760.4
2021	10.1		10.1
Thereafter	2,225.4		2,205.2
Total	$	3,189.7	$	3,116.2

On February 23, 2016, we gave notice of, and made an irrevocable commitment for, the redemption of $50 million of the outstanding principal amount of our existing 7.75% Senior Notes due 2022 (the “2022 Notes”). On March 24, 2016, we completed this redemption using cash on hand and capacity under our revolving credit facility. Pursuant to the terms of the 2022 Notes, this optional redemption was made at a price of 103.875%, which resulted in a total cash outlay of approximately $52 million. As a result of this redemption, we recorded a $2.4 million Loss on early extinguishment of debt in the first quarter of 2016.

On April 6, 2016, we gave notice of, and made an irrevocable commitment for, the redemption of an additional $50 million of the outstanding principal amount of the 2022 Notes. This optional redemption also will be made at a price of 103.875%, which will result in a total cash outlay of approximately $52 million when the transaction closes on May 6, 2016. We plan to use cash on hand and capacity under our revolving credit facility to fund the redemption. As a result of this redemption, we expect to record an approximate $2 million loss on early extinguishment of debt in the second quarter of 2016.

For additional information regarding our indebtedness, see Note 8, Long-term Debt, to the consolidated financial statements accompanying the 2015 Form 10-K.

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements


6.	Redeemable Noncontrolling Interests

The following is a summary of the activity related to our Redeemable noncontrolling interests during the three months ended March 31, 2016 and 2015 (in millions):



	Three Months Ended March 31,
	2016			2015
Balance at beginning of period	$	121.1		$	84.7
Net income attributable to noncontrolling interests	3.9			2.9
Distributions declared	(2.1		)	(1.7		)
Change in fair value	(26.7		)	(1.2		)
Balance at end of period	$	96.2		$	84.7

The following table reconciles the net income attributable to nonredeemable Noncontrolling interests, as recorded in the shareholders’ equity section of the condensed consolidated balance sheets, and the net income attributable to Redeemable noncontrolling interests, as recorded in the mezzanine section of the condensed consolidated balance sheets, to the Net income attributable to noncontrolling interests presented in the condensed consolidated statements of operations for the three months ended March 31, 2016 and 2015 (in millions):



	Three Months Ended March 31,
	Three Months Ended March 31,
	2016		2015
Net income attributable to nonredeemable noncontrolling interests	$	14.8	$	13.6
Net income attributable to redeemable noncontrolling interests	3.9		2.9
Net income attributable to noncontrolling interests	$	18.7	$	16.5

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements


7.	Fair Value Measurements

Our financial assets and liabilities that are measured at fair value on a recurring basis are as follows (in millions):



			Fair Value Measurements at Reporting Date Using
As of March 31, 2016	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Valuation Technique ⁽¹⁾
Other current assets:
Current portion of restricted marketable securities	$	16.0	$	—	$	16.0	$	—	M
Other long-term assets:
Restricted marketable securities	40.7		—		40.7		—		M
Redeemable noncontrolling interests	96.2		—		—		96.2		I
As of December 31, 2015
Other current assets:
Current portion of restricted marketable securities	$	16.1	$	—	$	16.1	$	—	M
Other long-term assets:
Restricted marketable securities	40.1		—		40.1		—		M
Redeemable noncontrolling interests	121.1		—		—		121.1		I

⁽¹⁾ The three valuation techniques are: market approach (M), cost approach (C), and income approach (I).

The fair values of our financial assets and liabilities are determined as follows:


•	Restricted marketable securities - The fair values of our available-for-sale restricted marketable securities are determined based on quoted market prices in active markets or quoted prices, dealer quotations, or alternative pricing sources supported by observable inputs in markets that are not considered to be active.

•

Redeemable noncontrolling interests - The fair value of the Redeemable noncontrolling interest related to our home health segment is determined using the product of a twelve-month specified performance measure and a specified median market price multiple based on a basket of public health companies. To determine the fair value of the Redeemable noncontrolling interests in our joint venture hospitals, we use the applicable hospitals’ projected operating results and cash flows discounted using a rate that reflects market participant assumptions for the applicable facilities. The projected operating results use management’s best estimates of economic and market conditions over the forecasted periods including assumptions for pricing and volume, operating expenses, and capital expenditures. See also Note 6, Redeemable Noncontrolling Interests.

In addition to assets and liabilities recorded at fair value on a recurring basis, we are also required to record assets and liabilities at fair value on a nonrecurring basis. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges or similar adjustments made to the carrying value of the applicable assets. During the three months ended March 31, 2016 and March 31, 2015, we did not record any gains or losses related to our nonfinancial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a nonrecurring basis as part of our continuing operations.

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

As discussed in Note 1, Summary of Significant Accounting Policies, “Fair Value Measurements,” to the consolidated financial statements accompanying the 2015 Form 10-K, the carrying value equals fair value for our financial instruments that are not included in the table below and are classified as current in our condensed consolidated balance sheets. The carrying amounts and estimated fair values for all of our other financial instruments are presented in the following table (in millions):



	As of March 31, 2016				As of December 31, 2015
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Long-term debt:
Advances under revolving credit facility	$	130.0	$	130.0	$	130.0	$	130.0
Term loan facilities	437.8		439.4		443.3		445.0
7.75% Senior Notes due 2022	124.8		131.5		174.3		183.7
5.125% Senior Notes due 2023	294.8		298.9		294.6		288.0
5.75% Senior Notes due 2024	1,192.7		1,218.0		1,192.6		1,146.0
5.75% Senior Notes due 2025	343.5		351.8		343.4		332.5
2.00% Convertible Senior Subordinated Notes due 2043	268.3		358.2		265.9		345.0
Other notes payable	38.4		38.4		39.2		39.2
Financial commitments:
Letters of credit	—		35.0		—		34.2

Fair values for our long-term debt and financial commitments are determined using inputs, including quoted prices in nonactive markets, that are observable either directly or indirectly, or Level 2 inputs within the fair value hierarchy. See Note 1, Summary of Significant Accounting Policies, “Fair Value Measurements,” to the consolidated financial statements accompanying the 2015 Form 10-K.


8.	Share-Based Payments

In February 2016, we issued a total of 0.7 million restricted stock awards to members of our management team. Approximately 0.2 million of these awards contain only a service condition, while the remainder contain both a service and a performance or market condition. For the awards that include a performance or market condition, the number of shares that will ultimately be granted to employees may vary based on the Company’s performance during the applicable two-year performance measurement period. Additionally, in February 2016, we granted 0.1 million stock options to members of our management team. The fair value of these awards and options was determined using the policies described in Note 1, Summary of Significant Accounting Policies, and Note 13, Share-Based Payments, to the consolidated financial statements accompanying the 2015 Form 10-K.


9.	Income Taxes

Our Provision for income tax expense of $39.7 million and $30.3 million for the three months ended March 31, 2016 and 2015, respectively, primarily resulted from the application of our estimated effective blended federal and state income tax rate.

The $145.0 million of net deferred tax assets included in the accompanying condensed consolidated balance sheet as of March 31, 2016 reflects management’s assessment it is more likely than not we will be able to generate sufficient future taxable income to utilize those deferred tax assets based on our current estimates and assumptions. As of March 31, 2016, we maintained a valuation allowance of $27.6 million due to uncertainties regarding our ability to utilize a portion of our state net operating losses (“NOLs”) and other credits before they expire. The amount of the valuation allowance has been determined for each tax jurisdiction based on the weight of all available evidence including management’s estimates of taxable income for each jurisdiction in which we operate over the periods in which the related deferred tax assets will be recoverable. It is possible we may be required to increase or decrease our valuation allowance at some future time if our forecast of future earnings varies

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

from actual results on a consolidated basis or in the applicable state tax jurisdictions, or if the timing of future tax deductions differs from our expectations.

We have significant federal and state NOLs that expire in various amounts at varying times through 2031. Our reported federal NOL of $64.1 million (approximately $183 million on a gross basis) as of March 31, 2016 excludes $15.5 million related to operating loss carryforwards resulting from excess tax benefits related to share-based awards, the tax benefits of which, when recognized, will be accounted for as a credit to Capital in excess of par value when they reduce taxes payable. At March 31, 2016, we had unused federal tax credit carryforwards of $15.0 million. These credit carryforwards expire in various amounts at various times through 2036.

Total remaining gross unrecognized tax benefits were $3.0 million and $2.9 million as of March 31, 2016 and December 31, 2015, respectively, all of which would affect our effective tax rate if recognized. A reconciliation of the beginning and ending liability for unrecognized tax benefits is as follows (in millions):



	Gross Unrecognized Income Tax Benefits
Balance at December 31, 2015	$	2.9
Gross amount of increases in unrecognized tax benefits related to current periods	0.1
Balance at March 31, 2016	$	3.0

Our continuing practice is to recognize interest and penalties related to income tax matters in income tax expense. Interest recorded as part of our income tax provision during the three months ended March 31, 2016 and 2015 was not material. Accrued interest income related to income taxes as of March 31, 2016 and December 31, 2015 was not material.

In December 2014, we signed an agreement with the IRS to begin participating in their Compliance Assurance Process, a program in which we and the IRS endeavor to agree on the treatment of significant tax positions prior to the filing of our federal income tax return. We signed a new agreement in December 2015 for the 2016 tax year. As a result of these agreements, the IRS surveyed our 2013, 2012, and 2011 federal income tax returns and will examine our 2015 and 2016 returns when filed. Our 2014 federal income tax return has been filed, and the IRS has not indicated its intent to examine or survey this return. The IRS is also separately examining the 2013 return of one of our partnership affiliates acquired in the CareSouth transaction. We have settled federal income tax examinations with the IRS for all tax years through 2012. Our state income tax returns are also periodically examined by various regulatory taxing authorities. We are currently under audit by seven states for tax years ranging from 2007 through 2014.

For the tax years that remain open under the applicable statutes of limitation, amounts related to unrecognized tax benefits have been considered by management in its estimate of our potential net recovery of prior years’ income taxes. Based on discussions with taxing authorities, we anticipate $0.5 million to $2.9 million of our unrecognized tax benefits may be released within the next 12 months.

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

10.Earnings per Common Share

The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):



	Three Months Ended March 31,
	2016			2015
Basic:
Numerator:
Income from continuing operations	$	76.8		$	59.3
Less: Net income attributable to noncontrolling interests included in continuing operations	(18.7		)	(16.5		)
Less: Income allocated to participating securities	(0.2		)	(0.3		)
Less: Convertible perpetual preferred stock dividends	—			(1.6		)
Income from continuing operations attributable to HealthSouth common shareholders	57.9			40.9
Loss from discontinued operations, net of tax, attributable to HealthSouth common shareholders	(0.1		)	(0.3		)
Net income attributable to HealthSouth common shareholders	$	57.8		$	40.6
Denominator:
Basic weighted average common shares outstanding	89.5			87.1
Basic earnings per share attributable to HealthSouth common shareholders:
Continuing operations	$	0.65		$	0.47
Discontinued operations	—			—
Net income	$	0.65		$	0.47

Diluted:
Numerator:
Income from continuing operations	$	76.8		$	59.3
Less: Net income attributable to noncontrolling interests included in continuing operations	(18.7		)	(16.5		)
Add: Interest on convertible debt, net of tax	2.4			2.3
Income from continuing operations attributable to HealthSouth common shareholders	60.5			45.1
Loss from discontinued operations, net of tax, attributable to HealthSouth common shareholders	(0.1		)	(0.3		)
Net income attributable to HealthSouth common shareholders	$	60.4		$	44.8
Denominator:
Diluted weighted average common shares outstanding	99.4			101.1
Diluted earnings per share attributable to HealthSouth common shareholders:
Continuing operations	$	0.61		$	0.44
Discontinued operations	—			—
Net income	$	0.61		$	0.44

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):



	Three Months Ended March 31,
	2016	2015
Basic weighted average common shares outstanding	89.5	87.1
Convertible perpetual preferred stock	—	3.2
Convertible senior subordinated notes	8.4	8.2
Restricted stock awards, dilutive stock options, restricted stock units, and common stock warrants	1.5	2.6
Diluted weighted average common shares outstanding	99.4	101.1

In October 2015 and February 2016, our board of directors declared cash dividends of $0.23 per share that were paid in January 2016 and April 2016, respectively. As of March 31, 2016 and December 31, 2015, accrued common stock dividends of $21.2 million and $21.3 million, respectively, were included in Accrued expenses and other current liabilities in our condensed consolidated balance sheets. Future dividend payments are subject to declaration by our board of directors.

The indenture underlying our convertible notes includes antidilutive protection that requires adjustments to the number of shares of common stock issuable upon conversion and the exercise price for common stock upon the occurrence of certain events, including payment of cash dividends on our common stock after a de minimis threshold. At issuance, the convertible notes had a conversion price of $39.65 per share, which was equal to an initial conversion rate of 25.2194 shares per $1,000 principal amount of the convertible notes. The payment of dividends on our common stock has triggered and will continue to trigger, from time to time, the antidilutive adjustment provisions of the convertible notes. The current conversion price of the convertible notes is $37.59 per share, and the conversion rate is 26.6011 for each $1,000 principal amount of the convertible notes.

See Note 8, Long-term Debt, Note 10, Convertible Perpetual Preferred Stock, and Note 16, Earnings per Common Share, to the consolidated financial statements accompanying the 2015 Form 10-K for additional information related to our convertible notes, common stock, common stock warrants, and convertible perpetual preferred stock.


11.	Contingencies and Other Commitments

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims, and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. The resolution of any such lawsuits, claims, or legal and regulatory proceedings could materially and adversely affect our financial position, results of operations, and cash flows in a given period.

Other Litigation—

We have been named as a defendant in a lawsuit filed March 28, 2003 by several individual stockholders in the Circuit Court of Jefferson County, Alabama, captioned Nichols v. HealthSouth Corp. The plaintiffs allege that we, some of our former officers, and our former investment bank engaged in a scheme to overstate and misrepresent our earnings and financial position. The plaintiffs are seeking compensatory and punitive damages. This case was stayed in the Circuit Court on August 8, 2005. The plaintiffs filed an amended complaint on November 9, 2010 to which we responded with a motion to dismiss filed on December 22, 2010. During a hearing on February 24, 2012, plaintiffs’ counsel indicated his intent to dismiss certain claims against us. Instead, on March 9, 2012, the plaintiffs amended their complaint to include additional securities fraud claims against HealthSouth and add several former officers to the lawsuit. On September 12, 2012, the plaintiffs further amended their complaint to request certification as a class action. One of those named officers has repeatedly attempted to remove the case to federal district court, most recently on December 11, 2012. We filed our latest motion to remand the case back to state court on January 10, 2013. On September 27, 2013, the federal court remanded the case back to state court. On November 25, 2014, the plaintiffs filed another amended complaint to assert new allegations relating to the time period of 1997 to 2002. On December 10, 2014, we filed a motion to dismiss on the grounds the plaintiffs lack standing because their claims are derivative

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

in nature, and the claims are time-barred by the statute of limitations. The court has scheduled a hearing for May 19, 2016 to consider our motion to dismiss.

We intend to vigorously defend ourselves in this case. Based on the stage of litigation, review of the current facts and circumstances as we understand them, the nature of the underlying claim, the results of the proceedings to date, and the nature and scope of the defense we continue to mount, we do not believe an adverse judgment or settlement is probable in this matter, and it is also not possible to estimate the amount of loss, if any, or range of possible loss that might result from an adverse judgment or settlement of this case.

Governmental Inquiries and Investigations—

On June 24, 2011, we received a document subpoena addressed to HealthSouth Hospital of Houston, a long-term acute care hospital (“LTCH”) we closed in August 2011, and issued from the Dallas, Texas office of the HHS-OIG. The subpoena stated it was in connection with an investigation of possible false or otherwise improper claims submitted to Medicare and Medicaid and requested documents and materials relating to patient admissions, length of stay, and discharge matters at this closed LTCH. We furnished the documents requested and have heard nothing from the HHS-OIG since December 2012.

On March 4, 2013, we received document subpoenas from an office of the HHS-OIG addressed to four of our hospitals. Those subpoenas also requested complete copies of medical records for 100 patients treated at each of those hospitals between September 2008 and June 2012. The investigation is being conducted by the United States Department of Justice (the “DOJ”). On April 24, 2014, we received document subpoenas relating to an additional seven of our hospitals. The new subpoenas reference substantially similar investigation subject matter as the original subpoenas and request materials from the period January 2008 through December 2013. Two of the four hospitals addressed in the original set of subpoenas have received supplemental subpoenas to cover this new time period. The most recent subpoenas do not include requests for specific patient files. However, in February 2015, the DOJ requested the voluntary production of the medical records of an additional 70 patients, some of whom were treated in hospitals not subject to the subpoenas, and we provided these records.

All of the subpoenas are in connection with an investigation of alleged improper or fraudulent claims submitted to Medicare and Medicaid and request documents and materials relating to practices, procedures, protocols and policies, of certain pre- and post-admissions activities at these hospitals including, among other things, marketing functions, pre-admission screening, post-admission physician evaluations, patient assessment instruments, individualized patient plans of care, and compliance with the Medicare 60% rule. Under the Medicare rule commonly referred to as the “60% rule,” an inpatient rehabilitation hospital must treat 60% or more of its patients from at least one of a specified list of medical conditions in order to be reimbursed at the inpatient rehabilitation hospital payment rates, rather than at the lower acute care hospital payment rates.

We are cooperating fully with the DOJ in connection with these subpoenas and are currently unable to predict the timing or outcome of the related investigations.

Other Matters—

The False Claims Act, 18 U.S.C. § 287, allows private citizens, called “relators,” to institute civil proceedings alleging violations of the False Claims Act. These qui tam cases are generally sealed by the court at the time of filing. The only parties typically privy to the information contained in the complaint are the relator, the federal government, and the presiding court. It is possible that qui tam lawsuits have been filed against us and that those suits remain under seal or that we are unaware of such filings or prevented by existing law, court order, or agreement with the government from discussing or disclosing the filing of such suits. We may be subject to liability under one or more undisclosed qui tam cases brought pursuant to the False Claims Act.

It is our obligation as a participant in Medicare and other federal healthcare programs to routinely conduct audits and reviews of the accuracy of our billing systems and other regulatory compliance matters. As a result of these reviews, we have made, and will continue to make, disclosures to the HHS-OIG and the United States Centers for Medicare and Medicaid Services relating to amounts we suspect represent over-payments from these programs, whether due to inaccurate billing or otherwise. Some of these disclosures have resulted in, or may result in, HealthSouth refunding amounts to Medicare or other federal healthcare programs.

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements


12.	Segment Reporting

Our internal financial reporting and management structure is focused on the major types of services provided by HealthSouth. We manage our operations using two operating segments which are also our reportable segments: (1) inpatient rehabilitation and (2) home health and hospice. These reportable operating segments are consistent with information used by our chief executive officer, who is our chief operating decision maker, to assess performance and allocate resources. The following is a brief description of our reportable segments:

•

Inpatient Rehabilitation - Our national network of inpatient rehabilitation hospitals stretches across 29 states and Puerto Rico, with a concentration of hospitals in the eastern half of the United States and Texas. As of March 31, 2016, we operate 122 inpatient rehabilitation hospitals, including one hospital that operates as a joint venture which we account for using the equity method of accounting. In addition, we manage four inpatient rehabilitation units through management contracts. We provide specialized rehabilitative treatment on both an inpatient and outpatient basis. Our inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

•

Home Health and Hospice - As of March 31, 2016, we provide home health and hospice services in 213 locations across 24 states. Two of these agencies operate as joint ventures which we account for using the equity method of accounting. Our home health services include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. We also provide specialized home care services in Texas and Kansas for pediatric patients with severe medical conditions. Our hospice services primarily include in-home services to terminally ill patients and their families to address patients’ physical needs, including pain control and symptom management, and to provide emotional and spiritual support.

The accounting policies of our reportable segments are the same as those described in Note 1, Basis of Presentation, “Variable Interest Entities,” to these condensed consolidated financial statements and Note 1, Summary of Significant Accounting Policies, to the consolidated financial statements accompanying the 2015 Form 10-K. All revenues for our services are generated through external customers. See Note 1, Basis of Presentation, “Net Operating Revenues,” for the payor composition of our revenues. No corporate overhead is allocated to either of our reportable segments. Our chief operating decision maker evaluates the performance of our segments and allocates resources to them based on adjusted earnings before interest, taxes, depreciation, and amortization (“Segment Adjusted EBITDA”).

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

Selected financial information for our reportable segments is as follows (in millions):



	Inpatient Rehabilitation						Home Health and Hospice
	Three Months Ended March 31,						Three Months Ended March 31,
	2016			2015			2016			2015
Net operating revenues	$	749.2		$	630.3		$	160.6		$	110.3
Less: Provision for doubtful accounts	(15.6		)	(11.0		)	(0.9		)	(0.6		)
Net operating revenues less provision for doubtful accounts	733.6			619.3			159.7			109.7
Operating expenses:
Inpatient rehabilitation:
Salaries and benefits	369.9			306.4			—			—
Other operating expenses	104.8			95.2			—			—
Supplies	32.4			29.8			—			—
Occupancy costs	15.6			10.4			—			—
Home health and hospice:
Cost of services sold (excluding depreciation and amortization)	—			—			78.4			53.4
Support and overhead costs	—			—			57.0			38.1
	522.7			441.8			135.4			91.5
Other income	(0.6		)	(0.5		)	—			—
Equity in net income of nonconsolidated affiliates	(2.2		)	(1.6		)	(0.2		)	—
Noncontrolling interests	16.8			15.2			1.9			1.3
Segment Adjusted EBITDA	$	196.9		$	164.4		$	22.6		$	16.9

Capital expenditures	$	38.7		$	26.3		$	0.4		$	0.3



	Inpatient Rehabilitation		Home Health and Hospice		HealthSouth Consolidated
As of March 31, 2016
Total assets	$	3,583.1	$	1,096.5	$	4,608.3
Investments in and advances to nonconsolidated affiliates	9.9		2.6		12.5
As of December 31, 2015
Total assets	$	3,589.0	$	1,088.4	$	4,606.1
Investments in and advances to nonconsolidated affiliates	9.3		2.4		11.7

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

Segment reconciliations (in millions):



	Three Months Ended March 31,
	2016			2015
Total segment Adjusted EBITDA	$	219.5		$	181.3
General and administrative expenses	(31.9		)	(34.6		)
Depreciation and amortization	(42.4		)	(31.9		)
(Loss) gain on disposal or impairment of assets	(0.2		)	1.5
Government, class action, and related settlements	—			(8.0		)
Professional fees - accounting, tax, and legal	(0.2		)	(2.2		)
Loss on early extinguishment of debt	(2.4		)	(1.2		)
Interest expense and amortization of debt discounts and fees	(44.6		)	(31.8		)
Net income attributable to noncontrolling interests	18.7			16.5
Income from continuing operations before income tax expense	$	116.5		$	89.6



	March 31, 2016			December 31, 2015
Total assets for reportable segments	$	4,679.6		$	4,677.4
Reclassification of deferred income tax liabilities to net deferred income tax assets	(71.3		)	(71.3		)
Total consolidated assets	$	4,608.3		$	4,606.1

Additional detail regarding the revenues of our operating segments by service line follows (in millions):



	Three Months Ended March 31,
	2016		2015
Inpatient rehabilitation:
Inpatient	$	719.4	$	606.6
Outpatient and other	29.8		23.7
Total inpatient rehabilitation	749.2		630.3
Home health and hospice:
Home health	150.9		103.9
Hospice	9.7		6.4
Total home health and hospice	160.6		110.3
Total net operating revenues	$	909.8	$	740.6


13.	Condensed Consolidating Financial Information

The accompanying condensed consolidating financial information has been prepared and presented pursuant to SEC Regulation S-X, Rule 3-10, “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.” Each of the subsidiary guarantors is 100% owned by HealthSouth, and all guarantees are full and unconditional and joint and several, subject to certain customary conditions for release. HealthSouth’s investments in its consolidated subsidiaries, as well as guarantor subsidiaries’ investments in nonguarantor subsidiaries and nonguarantor subsidiaries’ investments in guarantor subsidiaries, are presented under the equity method of accounting with the related investment presented within the line items Intercompany receivable and investments in consolidated affiliates and Intercompany payable in the accompanying condensed consolidating balance sheets.

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

The terms of our credit agreement allow us to declare and pay cash dividends on our common stock so long as: (1) we are not in default under our credit agreement and (2) our senior secured leverage ratio (as defined in our credit agreement) remains less than or equal to 1.75x. The terms of our senior note indenture allow us to declare and pay cash dividends on our common stock so long as (1) we are not in default, (2) the consolidated coverage ratio (as defined in the indenture) exceeds 2x or we are otherwise allowed under the indenture to incur debt, and (3) we have capacity under the indenture’s restricted payments covenant to declare and pay dividends. See Note 8, Long-term Debt, to the consolidated financial statements accompanying the 2015 Form 10-K.

Periodically, certain wholly owned subsidiaries of HealthSouth make dividends or distributions of available cash and/or intercompany receivable balances to their parents. In addition, HealthSouth makes contributions to certain wholly owned subsidiaries. When made, these dividends, distributions, and contributions impact the Intercompany receivable, Intercompany payable, and HealthSouth shareholders’ equity line items in the accompanying condensed consolidating balance sheet but have no impact on the consolidated financial statements of HealthSouth Corporation.

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

Condensed Consolidating Statement of Operations



	Three Months Ended March 31, 2016
	HealthSouth Corporation			Guarantor Subsidiaries			Nonguarantor Subsidiaries			Eliminating Entries			HealthSouth Consolidated
	(In Millions)
Net operating revenues	$	4.9		$	550.7		$	383.2		$	(29.0	)	$	909.8
Less: Provision for doubtful accounts	—			(11.9		)	(4.6		)	—			(16.5		)
Net operating revenues less provision for doubtful accounts	4.9			538.8			378.6			(29.0		)	893.3
Operating expenses:
Salaries and benefits	11.3			255.0			224.4			(4.6		)	486.1
Other operating expenses	5.4			77.1			47.8			(11.1		)	119.2
Occupancy costs	0.9			23.0			7.4			(13.3		)	18.0
Supplies	—			23.2			11.8			—			35.0
General and administrative expenses	33.2			—			(1.3		)	—			31.9
Depreciation and amortization	2.4			25.7			14.3			—			42.4
Professional fees—accounting, tax, and legal	0.2			—			—			—			0.2
Total operating expenses	53.4			404.0			304.4			(29.0		)	732.8
Loss on early extinguishment of debt	2.4			—			—			—			2.4
Interest expense and amortization of debt discounts and fees	38.9			5.2			5.3			(4.8		)	44.6
Other income	(4.7		)	(0.1		)	(0.6		)	4.8			(0.6		)
Equity in net income of nonconsolidated affiliates	—			(2.1		)	(0.3		)	—			(2.4		)
Equity in net income of consolidated affiliates	(86.2		)	(8.2		)	—			94.4			—
Management fees	(34.2		)	26.2			8.0			—			—
Income from continuing operations before income tax (benefit) expense	35.3			113.8			61.8			(94.4		)	116.5
Provision for income tax (benefit) expense	(22.8		)	45.4			17.1			—			39.7
Income from continuing operations	58.1			68.4			44.7			(94.4		)	76.8
Loss from discontinued operations, net of tax	(0.1		)	—			—			—			(0.1		)
Net income	58.0			68.4			44.7			(94.4		)	76.7
Less: Net income attributable to noncontrolling interests	—			—			(18.7		)	—			(18.7		)
Net income attributable to HealthSouth	$	58.0		$	68.4		$	26.0		$	(94.4	)	$	58.0
Comprehensive income	$	58.1		$	68.4		$	44.7		$	(94.4	)	$	76.8
Comprehensive income attributable to HealthSouth	$	58.1		$	68.4		$	26.0		$	(94.4	)	$	58.1

HealthSouth Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements

Condensed Consolidating Statement of Operations



	Three Months Ended March 31, 2015
	HealthSouth Corporation			Guarantor Subsidiaries			Nonguarantor Subsidiaries			Eliminating Entries			HealthSouth Consolidated
	(In Millions)
Net operating revenues	$	5.3		$	456.8		$	303.2		$	(24.7	)	$	740.6
Less: Provision for doubtful accounts	—			(9.0		)	(2.6		)	—			(11.6		)
Net operating revenues less provision for doubtful accounts	5.3			447.8			300.6			(24.7		)	729.0
Operating expenses:
Salaries and benefits	8.1			211.1			170.0			(4.1		)	385.1
Other operating expenses	9.5			63.1			41.0			(10.4		)	103.2
Occupancy costs	1.1			15.3			5.9			(10.2		)	12.1
Supplies	—			20.8			10.6			—			31.4
General and administrative expenses	34.3			—			0.3			—			34.6
Depreciation and amortization	2.3			19.1			10.5			—			31.9
Government, class action, and related settlements	8.0			—			—			—			8.0
Professional fees—accounting, tax, and legal	2.2			—			—			—			2.2
Total operating expenses	65.5			329.4			238.3			(24.7		)	608.5
Loss on early extinguishment of debt	1.2			—			—			—			1.2
Interest expense and amortization of debt discounts and fees	29.2			2.3			2.7			(2.4		)	31.8
Other income	(2.3		)	—			(0.6		)	2.4			(0.5		)
Equity in net income of nonconsolidated affiliates	—			(1.6		)	—			—			(1.6		)
Equity in net income of consolidated affiliates	(78.6		)	(8.1		)	—			86.7			—
Management fees	(28.5		)	21.7			6.8			—			—
Income from continuing operations before income tax (benefit) expense	18.8			104.1			53.4			(86.7		)	89.6
Provision for income tax (benefit) expense	(24.0		)	39.6			14.7			—			30.3
Income from continuing operations	42.8			64.5			38.7			(86.7		)	59.3
Loss from discontinued operations, net of tax	(0.3		)	—